These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6403891)

  • 1. Methsuximide for complex partial seizures: efficacy, toxicity, clinical pharmacology, and drug interactions.
    Browne TR; Feldman RG; Buchanan RA; Allen NC; Fawcett-Vickers L; Szabo GK; Mattson GF; Norman SE; Greenblatt DJ
    Neurology; 1983 Apr; 33(4):414-8. PubMed ID: 6403891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective and safe but forgotten: methsuximide in intractable epilepsies in childhood.
    Sigler M; Strassburg HM; Boenigk HE
    Seizure; 2001 Mar; 10(2):120-4. PubMed ID: 11407955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Methsuximide in the treatment of epilepsies (author's transl)].
    Stenzel E; Boenigk HE; Rambeck B
    Nervenarzt; 1977 Jul; 48(7):377-82. PubMed ID: 578567
    [No Abstract]   [Full Text] [Related]  

  • 4. Anticonvulsant drugs. I. Patho-physiological and pharmacological aspects.
    Kutt H; Louis S
    Drugs; 1972; 4(3):227-55. PubMed ID: 4405017
    [No Abstract]   [Full Text] [Related]  

  • 5. Monitoring drug concentrations in a case of combined overdosage with primidone and methsuximide.
    Johnson GF; Least CJ; Serum JW; Solow EB; Solomon HM
    Clin Chem; 1976 Jun; 22(6):915-21. PubMed ID: 946953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methsuximide for refractory complex partial seizures.
    Wilder BJ; Buchanan RA
    Neurology; 1981 Jun; 31(6):741-4. PubMed ID: 6894634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methsuximide for intractable childhood seizures.
    Tennison MB; Greenwood RS; Miles MV
    Pediatrics; 1991 Feb; 87(2):186-9. PubMed ID: 1987529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of "benign" partial epilepsies of childhood, including atypical forms.
    Gross-Selbeck G
    Neuropediatrics; 1995 Feb; 26(1):45-50. PubMed ID: 7791951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma concentrations of phensuximide, methsuximide, and their metabolites in relation to clinical efficacy.
    Porter RJ; Penry JK; Lacy JR; Newmark ME; Kupferberg HJ
    Neurology; 1979 Nov; 29(11):1509-13. PubMed ID: 116142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiepileptic monotherapy and combination therapy of simple focal seizures].
    Fröscher W; Stoll KD
    Fortschr Neurol Psychiatr; 1985 Dec; 53(12):447-53. PubMed ID: 3935555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of methsuximide and N-desmethylmethsuximide during methsuximide therapy.
    Strong JM; Abe T; Gibbs EL; Atkinson AJ
    Neurology; 1974 Mar; 24(3):250-5. PubMed ID: 4855951
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of N-hydroxymethyl-p-isopropoxyphenylsuccinimide on the anticonvulsant action of different classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model.
    Luszczki JJ; Kominek M; Florek-Luszczki M; Tchaytchian DA; Kocharov SL; Zolkowska D
    Epilepsy Res; 2012 Jun; 100(1-2):27-36. PubMed ID: 22281062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vigabatrin for refractory complex partial seizures: multicenter single-blind study with long-term follow-up.
    Browne TR; Mattson RH; Penry JK; Smith DB; Treiman DM; Wilder BJ; Ben-Menachem E; Napoliello MJ; Sherry KM; Szabo GK
    Neurology; 1987 Feb; 37(2):184-9. PubMed ID: 3808298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacotherapy of epilepsy--current problems and controversies].
    Schmidt D
    Fortschr Neurol Psychiatr; 1983 Nov; 51(11):363-86. PubMed ID: 6418628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome evaluation of gabapentin as add-on therapy for partial seizures. "NEON" Study Investigators Group. Neurontin Evaluation of Outcomes in Neurological Practice.
    Bruni J
    Can J Neurol Sci; 1998 May; 25(2):134-40. PubMed ID: 9604135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part I: Phenobarbital, primidone, valproic acid, ethosuximide and mesuximide.
    Battino D; Estienne M; Avanzini G
    Clin Pharmacokinet; 1995 Oct; 29(4):257-86. PubMed ID: 8549027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of anticonvulsants.
    Hvidberg EF; Dam M
    Clin Pharmacokinet; 1976; 1(3):161-88. PubMed ID: 797496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenytoin desensitization in a child with symptomatic localization-related epilepsy.
    Itomi S; Okumura A; Ikuta T; Negoro T; Watanabe K
    Brain Dev; 2007 Mar; 29(2):121-3. PubMed ID: 16935446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoniazid as an inhibitor of primidone metabolism.
    Sutton G; Kupferberg HJ
    Neurology; 1975 Dec; 25(12):1179-81. PubMed ID: 812007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.